An enthusiastic & motivated researcher pursuing a Ph.D. in Nuclear Medicine especially focused on Radionuclide therapy with 188Re-Lipiodol and 90Y-microsphere in Hepatocellular carcinoma (HCC), Locally advanced Ca. Gall Bladder, Metastatic lung lesions and recurrent Glioblastoma. Skilled in Internal dosimetry in TARE, and texture feature extraction in PET images. In context to radiopharmacy, i have hand-on experience of in-vivo labeling of RBC & denatured RBC procedure and preparation and quality control of various generator produced radionuclides (99mTc, 68Ga, and 188Re) and cyclotron produced (18F labeled NaF, FDG, and 13N Ammonia) labeling.Strong background in radiation therapy (external beam radiotherapy and HDR brachytherapy) and Nuclear Medicine internal radionuclide dosimetry.Ability to collaborate & work with a multidisciplinary team of interventional radiologists, Nuclear Medicine Physicist, diagnostic radiologists, and hepatologists in understanding liver response to radiation injury with multiparametric MR methods.Experience in administration of Radiopharmaceutical therapy:❖ Iodine therapy- NaI and MIBG therapy❖ 177Lu Therapy-DOTATATE, PSMA, FAPi and colloid (radiosynovectomy)❖ 188Rhenium Therapy-Colloid (Radiosynovectomy), Lipiodol (TART)❖ 90Y-microsphere TARE in HCC, Locally advanced Ca. Gall Bladder, Metastatic lung lesions and recurrent Glioblastoma➢ Working knowledge of radiation safety aspects of nuclear medicine and well versed withthe radiation monitoring equipment including their Quality Control such as IonisationChamber, TLD, GM counter, and Film Batch.➢ Followed radiation safety techniques in the use and disposal of radioactive materials andregulations for the shipping and receiving of radioactive isotopes.➢Having sound knowledge of Microsoft office, operating the windows & internet explorer